Anemia In Dialysis Patients - Peginesatide Gets Green Light From FDA Advisory ... - Medical News Today Print
Medical News Today
An FDA Advisory Committee has voted in favour of approving peginesatide for use with dialysis patients who developed anemia caused by CKD (chronic kidney disease). The Oncologic Drugs Advisory Committee (ODAC) voted 15 in favor, 1 against, ...
FDA Panel Gives Nod to Affymax Drug for Anemia Fox News
FDA Panel Endorses ESA for Patients on Dialysis MedPage Today
Nektar Reports Affymax Announced FDA Advisory Committee Voted in Favor of

...